IpiNovyx Bio Competitors and Similar CompaniesClear all
IpiNovyx Bio's competitors and similar companies include ProteinQure, PharmEnable, Naicons and Juvena Therapeutics.
 PharmEnable PharmEnable is a biotech company supporting early drug discovery programs by providing a platform to identify new candidates. |  Juvena Therapeutics Juvena Therapeutics is a biotechnological company that researches, develops, and commercializes tissue restorative biologics to treat myopathies and metabolic diseases. | ||||
Founding Date | Founding Date 2021 | Founding Date 2017 | Founding Date 2016 | Founding Date 2006 | Founding Date 2017 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations West Nyack, US HQ | Locations Toronto, CA HQ | Locations Cambridge, GB HQ Cambridge, GB | Locations Milano, IT HQ Saronno, IT | Locations Redwood City, US HQ |
Employees | Employees 614% decrease | Employees 359% increase | Employees 1818% decrease | Employees 13 | Employees 43 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 4m (almost 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 41m (over 3 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 4.6m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 57.4m |
For sources of this data, please see the company profile
View Company Profiles
ProteinQure
HQ
Toronto, CA
Employees
35↑ 9% increase
ProteinQure is a company that provides biotech solutions.
View companyPharmEnable
HQ
Cambridge, GB
Employees
18↓ 18% decrease
PharmEnable is a biotech company supporting early drug discovery programs by providing a platform to identify new candidates.
View company
Naicons
HQ
Milano, IT
Employees
13
Naicons is a biotechnology company devoted to the development of bioactive compounds.
View companyJuvena Therapeutics
HQ
Redwood City, US
Employees
43
Juvena Therapeutics is a biotechnological company that researches, develops, and commercializes tissue restorative biologics to treat myopathies and metabolic diseases.
View company